378
G. Wang et al. / Journal of Molecular Structure 1036 (2013) 372–379
Table 4
compound 1 at DFT level agree well with the experimental data.
On the other hand, we explored the methylation reaction of 1-phe-
nyl-2-thiobarbituric acid for the first time. There are three possible
dimethylation products for compound 1 and we just observed one
product in the reaction. The methylated site was identified exper-
imentally (X-ray, FT-IR) and theoretically (transition state search,
energy calculation), the results revealed that theoretical calcula-
tions are in good agreement with experimental data. In summary,
this work demonstrates the combination of experimental and the-
oretical methods to improve knowledge of tautomerism equilib-
rium and reactivity of 1-phenyl-2-thiobarbituric acid and may
help in synthesizing novel thiobarbituric acid derivatives.
The energy gap between N6 and other tautomers (kcal/mol).
Tautomers
Gas
CHCl3
EtOH
DMSO
N1
N2
N3
N4
N5
N6
N7
N8
15.56
25.04
12.30
8.16
13.55
0
12.17
33.07
13.62
8.60
14.68
0
18.01
29.24
15.00
9.91
15.12
0
13.05
30.43
15.25
10.29
15.37
0
15.00
19.39
15.69
18.70
17.69
20.71
18.32
20.52
Acknowledgements
Table 5
The energy of possible methylated products in gas phase and DMF solution.
The authors would like to thank Scientific Computing & Model-
ling (SCM) for allowing us to utilize their software for this study,
and also thank Beijing Computing Center for their computational
resource. We also gratefully acknowledge financial support from
the National Natural Science Foundation of China (Grants
81230077 and 81102379) and the Education Department of
Liaoning Province (Grant L2011174).
Gas (a.u)
DMF (a.u)
2a
2b
2c
À1122.4382
À1122.3992
À1122.4217
À1122.4219
À1122.3796
À1122.4092
as expected because the N-phenyl substitution reduces a mobile H
atom consequently reduces a methylation site. But 1-phenyl-2-
thiobarbituric acid has three potential methylation site (sulfur
atom and two oxygen atoms). And as observed in the 1H NMR spec-
trum in DMF-d7, we found that tautomerization of compound 1 oc-
curs but the exact tautomer (N3 or N4) could not be identified.
Accordingly we conclude that there might be three possible meth-
ylated products (Fig. 2) of 1-phenyl-2-thiobarbituric acid using
DMF as reaction solvent. But we only observed one product after
the reaction so that a problem arise that which two sites had been
methylated. In order to determine the methylation site, theoretical
calculations were carried out to assist experimental data. First we
searched the transition state of the methylation reaction using ADF
software at DFT level finding that there is no transition state in the
reaction process, the energy kept decreasing during the whole pro-
cess. Consequently the methylation reaction will generate the most
energetically stable product. Therefore, we calculated the energy
for the three possible methylated products 2a–2c in gas phase
and in its reaction solvent (DMF). The calculated energy is pre-
sented in Table 5. It can be seen from Table 5, that 2a is the most
energetically stable one among the three isomers both in gas phase
and in DMF solution. The energy sequence of the three isomers is
2a < 2c < 2b. So that 2a should be the theoretical product for the
methylation reaction of 1-phenyl-2-thiobarbituric acid. As de-
scribed in Section 3.1, the molecular structure of methylation reac-
tion product was experimentally identified by X-ray diffraction to
be 2a which verified the calculated results. And no other isomers
were observed. In summary, the methylation reaction of 1-phe-
nyl-2-thiobarbituric acid was investigated theoretically (DFT) and
experimentally (X-ray, IR) and we found that the calculated results
are in good accordance with experimental data.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
References
[1] A.N. Osman, M.M. Kandeel, M.M. Said, E.M. Ahmed, Indian J. Chem., Sect. B:
Org. Chem. Incl. Med. Chem. 35 (1996) 1073.
[2] A. Agarwal, S. Lata, K.K. Saxena, V.K. Srivastava, A. Kumar, Eur. J. Med. Chem. 41
(2006) 1223.
[3] T.J. Haley, J.T. Gidley, Eur. J. Pharmacol. 36 (1976) 211.
[4] A.D. Brewer, J.A. Minatelli, J. Plowman, K.D. Paull, V.L. Narayanan, Biochem.
Pharmacol. 34 (1985) 2047.
[5] Q. Cheng, Q. Wang, T. Tan, M. Wang, N. Chen, Chin. J. Chem. 30 (2012) 386.
[6] T. Matsushita, J. Am. Oil Chem. Soc. 87 (2010) 963.
[7] D. Zhang, J. Zhang, M. Li, W. Li, G. Aimaiti, G. Tuersun, J. Ye, Q. Chu, Food Chem.
129 (2011) 206.
[8] J. Nawrot-Modranka, E. Nawrot, J. Graczyk, Eur. J. Med. Chem. 41 (2006) 1301.
[9] M.-l. Huang, J.-w. Zou, D.-y. Yang, B.-z. Ning, Z.-c. Shang, Q.-s. Yu, J. Mol. Struct.
– Theochem. 589–590 (2002) 321.
[10] K. Sztanke, S. Fidecka, E. Ke˛dzierska, Z. Karczmarzyk, K. Pihlaja, D. Matosiuk,
Eur. J. Med. Chem. 40 (2005) 127.
[11] M. Pitucha, Z. Karczmarzyk, W. Wysocki, A.A. Kaczor, D. Matosiuk, J. Mol.
Struct. 994 (2011) 313.
[12] Ç. Albayrak, G. Kasßtaßs, M. Odabasßog˘lu, O. Büyükgüngör, J. Mol. Struct. 1000
(2011) 162.
[13] M. Costas, R. Acevedo-Chávez, J. Solution Chem. 41 (2012) 864.
[14] K.-H. Cho, J. Choo, S.-W. Joo, J. Mol. Struct. 738 (2005) 9.
[15] A. Encinas, A. Castro, N.E. Campillo, J.A. Páez, Eur. J. Org. Chem. 2007 (2007)
5603.
[16] F. Freeman, H.N. Po, J. Phys. Chem. A. 110 (2006) 7904.
[17] S. Millefiori, A. Millefiori, J. Heterocycl. Chem. 26 (1989) 639.
[18] E. Méndez, M.F. Cerdá, J.S. Gancheff, J. Torres, C. Kremer, J. Castiglioni, M.
Kieninger, O.N. Ventura, J. Phys. Chem. C. 111 (2007) 3369.
[19] M.R. Chierotti, L. Ferrero, N. Garino, R. Gobetto, L. Pellegrino, D. Braga, F.
Grepioni, L. Maini, Chem. Eur. J. 16 (2010) 4347.
[20] D. Rotili, D. Tarantino, V. Carafa, E. Lara, S. Meade, G. Botta, A. Nebbioso, J.
Schemies, M. Jung, A.G. Kazantsev, M. Esteller, M.F. Fraga, L. Altucci, A. Mai,
ChemMedChem 5 (2010) 674.
[21] T.D. Mckee, R.K. Suto, T. Tibbitts, J. Sowadski, PCT Int. Appl. WO2003074497.
2003.
[22] V.V. Tets, G.V. Tets, K.A. Krasnov, RU2428182. 2011.
[23] S. Akiyama, K. Nakashima, S.i. Nakatsuji, M. Suzuki, C. Umekawa, Dyes
Pigment. 8 (1987) 459.
[24] K.A. Krasnov, V.G. Kartsev, M.N. Yurova, Chem. Nat. Compd. 37 (2001) 543.
[25] T.D. Venu, S.A. Khanum, A. Firdouse, B.K. Manuprasad, S. Shashikanth, R.
Mohamed, B.S. Vishwanth, Bioorg. Med. Chem. Lett. 18 (2008) 4409.
[26] P. Crepaldi, B. Cacciari, M.-C. Bonache, G. Spalluto, K. Varani, P.A. Borea, Bioorg.
Med. Chem. 17 (2009) 4612.
4. Conclusions
In this study, 1-phenyl-2-thiobarbituric acid and its methylated
derivative were synthesized and their molecular structure and tau-
tomeric characteristic were investigated by experimental and com-
putational techniques. FT-IR and X-ray diffraction studies indicate
that in solid state 1-phenyl-2-thiobarbituric acid (compound 1) ex-
ists in the triketo form. 1H NMR study shows that in CDCl3 solution
compound 1 also exists in triketo form whereas in DMSO-d6, DMF-
d7 and CD3OD solution tautomerization occurs, indicating that the
tautomerization in polar solvents occurs easier than in apolar
solvents. The geometric optimization and energy calculation of
[27] R.N. Mirrington, G.I. Feutrill, Org. Synth. 6 (1988) 859.
[28] G.M. Sheldrick, Acta Crystallogr., Sect. A. 64 (2008) 112.